About the Exploring the Role of Microbiome in Cancer Session
The role of the microbiome in cancer is an area of intense research, as scientists uncover the complex relationship between the microorganisms residing in our bodies and cancer development. Studies have shown that the gut microbiome can influence immune responses, inflammation, and the effectiveness of cancer therapies. Some microbiota may promote carcinogenesis by producing metabolites that alter the tumor microenvironment, while others may have protective effects. Researchers are investigating how the microbiome can be modulated to enhance cancer treatments, such as immunotherapy or chemotherapy. Understanding these interactions could lead to the development of microbiome-based therapies, such as probiotics or dietary interventions, to improve cancer treatment outcomes and reduce side effects.
Topics Covered in Exploring the Role of Microbiome in Cancer
Gut Dysbiosis
Microbial Metabolites
Microbe-Driven Inflammation
Intratumoral Bacteria
Immunotherapy Response
Fecal Microbiota Transplant
Related Scientific Sessions at CIOC 2027
Why Attend the Exploring the Role of Microbiome in Cancer Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Exploring the Role of Microbiome in Cancer work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Exploring the Role of Microbiome in Cancer research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Exploring the Role of Microbiome in Cancer track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Exploring the Role of Microbiome in Cancer Conference 2027 — FAQs
What is the Exploring the Role of Microbiome in Cancer track at CIOC 2027?
The Exploring the Role of Microbiome in Cancer track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Exploring the Role of Microbiome in Cancer. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Exploring the Role of Microbiome in Cancer sessions?
Cancer researchers and clinicians, educators and students with an interest in Exploring the Role of Microbiome in Cancer are all welcome — whether presenting or attending.
Can I present my research in the Exploring the Role of Microbiome in Cancer track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Exploring the Role of Microbiome in Cancer sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Exploring the Role of Microbiome in Cancer track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.